9:16AM ET 5/20/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
9:10AM ET 5/20/2022 MT NewswiresAbbVie (ABBV) said Friday it has filed a new drug application with the US Food and Drug Administration for its ABBV-951 treatment of motor fluctuations in...
5:16PM ET 5/18/2022 MT NewswiresMichael Severino, Vice Chairman, on May 16, 2022, sold 200,000 shares in Abbvie (ABBV) for $30,849,488. Following the Form 4 filing with the SEC, Severino...
5:16PM ET 5/18/2022 MT NewswiresHenry O Gosebruch, Executive Vice President, Chief Strategy Officer, on May 16, 2022, sold 83,960 shares in Abbvie (ABBV) for $13,013,800. Following the...